Insider · CIK 0001317917

Thistle Mary

Reports to the SEC for 8 companies · WALTHAM, MA

sec.gov

Transactions

Companies

Filings

CIK

0001317917

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-16	CGEMCullinan Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+25.3K sh	—	—	25,319
2026-06-12	QTTBQ32 Bio Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+10.8K sh	—	—	10,826
2026-06-12	QTTBQ32 Bio Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+9,810 sh	—	—	9,810
2026-06-10	TRDAEntrada Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+19K sh	—	—	19,000
2025-10-23	QTTBQ32 Bio Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+53.5K sh	—	—	53,521
2025-08-05	Vigil Neuroscience, Inc.D Disposition to Issuer	Director	DDisposition to Issuer	−5,000 sh	—	—	0
2025-08-05	Vigil Neuroscience, Inc.Stock Option Award (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−18.1K sh	—	—	0
2025-08-05	Vigil Neuroscience, Inc.Stock Option Award (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−13.9K sh	—	—	0
2025-08-05	Vigil Neuroscience, Inc.Stock Option Award (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−24.3K sh	—	—	0
2025-08-05	Vigil Neuroscience, Inc.Stock Option Award (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−12.2K sh	—	—	0
2025-06-11	TRDAEntrada Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+19K sh	—	—	19,000
2025-05-22	Vigil Neuroscience, Inc.A Award	Director	AAward	+5,000 sh	—	—	5,000
2025-02-24	QTTBQ32 Bio Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−12.8K sh	—	—	0
2025-02-24	QTTBQ32 Bio Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+12.8K sh	—	—	12,767
2024-08-08	CGEMCullinan Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+25.7K sh	—	—	25,743
2024-06-13	TRDAEntrada Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+16K sh	—	—	16,000
2024-06-05	Vigil Neuroscience, Inc.Stock Option Award (Right to Buy)A Award	Director	AAward	+18.1K sh	—	—	18,068
2024-05-03	Vigil Neuroscience, Inc.Stock Option Award (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−24.3K sh	—	—	0
2024-05-03	Vigil Neuroscience, Inc.Stock Option Award (Right to Buy)A Award	Director	AAward	+24.3K sh	—	—	24,309
2024-05-03	Vigil Neuroscience, Inc.Stock Option Award (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−12.2K sh	—	—	0
2024-05-03	Vigil Neuroscience, Inc.Stock Option Award (Right to Buy)A Award	Director	AAward	+12.2K sh	—	—	12,155
2024-05-03	Vigil Neuroscience, Inc.Stock Option Award (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−13.9K sh	—	—	0
2024-05-03	Vigil Neuroscience, Inc.Stock Option Award (Right to Buy)A Award	Director	AAward	+13.9K sh	—	—	13,928
2024-03-25	QTTBQ32 Bio Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+12.8K sh	—	—	12,767
2023-06-14	QTTBQ32 Bio Inc. · Option (Right to Buy)A Award	Director	AAward	+23K sh	—	—	23,000
2023-06-08	TRDAEntrada Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+16K sh	—	—	16,000
2023-06-07	Vigil Neuroscience, Inc.Stock Option Grant (Right to Buy)A Award	Director	AAward	+13.9K sh	—	—	13,928
2023-06-06	TCRTAlaunos Therapeutics, Inc. · Employee Stock Option (right to buy)A Award	Director	AAward	+100K sh	—	—	100,000
2022-06-22	TCRTAlaunos Therapeutics, Inc.A Award	Director	AAward	+40K sh	—	—	45,000
2022-06-22	TCRTAlaunos Therapeutics, Inc. · Employee Stock Option (right to buy)A Award	Director	AAward	+100K sh	—	—	100,000
2022-06-22	TCRTAlaunos Therapeutics, Inc.A Award	Director	AAward	+40K sh	—	—	45,000
2022-06-22	TCRTAlaunos Therapeutics, Inc. · Employee Stock Option (right to buy)A Award	Director	AAward	+100K sh	—	—	100,000
2022-06-15	QTTBQ32 Bio Inc. · Option (Right to Buy)A Award	Director	AAward	+18K sh	—	—	18,000
2022-06-09	Vigil Neuroscience, Inc.Stock Option Grant (Right to Buy)A Award	Director	AAward	+12.2K sh	—	—	12,155
2022-06-02	TRDAEntrada Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+11.9K sh	—	—	11,918
2022-04-18	Vigil Neuroscience, Inc.Stock Option Grant (Right to Buy)A Award	Director	AAward	+24.3K sh	—	—	24,309
2021-10-28	TRDAEntrada Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+11.9K sh	—	—	11,918
2021-06-17	QTTBQ32 Bio Inc. · Option (Right to Buy)A Award	Director	AAward	+18K sh	—	—	18,000
2021-03-04	TCRTAlaunos Therapeutics, Inc.A Award	Director	AAward	+5,000 sh	—	—	5,000
2021-03-04	TCRTAlaunos Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+37.5K sh	—	—	37,500
2021-03-04	TCRTAlaunos Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+150K sh	—	—	150,000
2020-06-10	QTTBQ32 Bio Inc. · Option (Right to Buy)A Award	Director	AAward	+18K sh	—	—	18,000
2019-06-06	QTTBQ32 Bio Inc. · Option (Right to Buy)A Award	Director	AAward	+15.6K sh	—	—	15,580
2018-03-27	QTTBQ32 Bio Inc. · Employee stock optionA Award	Director	AAward	+31.2K sh	—	—	31,160
2017-11-07	Dimension Therapeutics, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Chief Operating Officer	DDisposition to Issuer	−27.7K sh	—	—	0
2017-11-07	Dimension Therapeutics, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Chief Operating Officer	DDisposition to Issuer	−181K sh	—	—	0
2017-11-07	Dimension Therapeutics, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Chief Operating Officer	DDisposition to Issuer	−17.1K sh	—	—	0
2017-11-07	Dimension Therapeutics, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Chief Operating Officer	DDisposition to Issuer	−65K sh	—	—	0
2017-11-07	Dimension Therapeutics, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Chief Operating Officer	DDisposition to Issuer	−60K sh	—	—	0
2017-02-01	Dimension Therapeutics, Inc.Stock Option (Right to Buy)A Award	Chief Operating Officer	AAward	+60K sh	—	—	60,000

Recent filings

Accepted (ET)
Jul 214/A
Thistle Mary0001193125-26-310965
SEC(opens sec.gov)
Jun 184
Thistle Mary0001193125-26-276055
SEC(opens sec.gov)
Jun 164
Thistle Mary0001193125-26-272690
SEC(opens sec.gov)
Jun 124
Thistle Mary0001689375-26-000036
SEC(opens sec.gov)
Oct 274
Thistle Mary0001193125-25-251986
SEC(opens sec.gov)
Aug 54
Thistle Mary0000950170-25-102504
SEC(opens sec.gov)
Jun 124
Thistle Mary0001689375-25-000032
SEC(opens sec.gov)
May 234
Thistle Mary0000950170-25-077267
SEC(opens sec.gov)
Feb 264
Thistle Mary0000950170-25-028247
SEC(opens sec.gov)
Aug 94
Thistle Mary0000950170-24-094861
SEC(opens sec.gov)
Jun 144
Thistle Mary0001689375-24-000036
SEC(opens sec.gov)
Jun 74
Thistle Mary0000950170-24-070842
SEC(opens sec.gov)
May 74
Thistle Mary0000950170-24-054698
SEC(opens sec.gov)

Companies

Address

Q32 BIO INC. 830 WINTER STREET

WALTHAM, MA, 02451